Ledger.Open graph →
SEC Form D · filed February 13, 2024

NEURONA THERAPEUTICS, INC

Offering
$120.0M
Sold
$120.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Ray Kelleher · South San Francisco, CADirectorCory Nicholas · South San Francisco, CAExec · Director · PromoterJames Stutz · South San Francisco, CAExecRobert Tjian · South San Francisco, CADirectorTim Kutzkey · South San Francisco, CADirectorBrad Margus · South San Francisco, CADirectorLeo R. Guthart · South San Francisco, CADirectorJoel Cooperman · New York, NYDirectorRay Kelleher · South San Francisco, CADirectorMicah Kinsler · Suite 101, AZDirectorJames Stutz · South San Francisco, CAExecAlan Badey · New York, NYExec · Director · PromoterCatherine Sohn · South San Francisco, CADirectorWilliam R. Woo · New York, NYDirectorErica Whitaker · South San Francisco, CADirectorAlger A. St-Jean · Toronto, Ontario, CanadaDirectorDhivya Venkat · London, United KingdomDirectorSabrina Hahn · Alpine, NJDirectorMinyoung Sohn · Denver, COExec · Director · PromoterMoshe Lifschitz · Englewood, NJDirectorJeffrey F. O'Donnell Sr · Malvern, PADirectorJohnathan L. Manning · Savannah, GAExecErica Whitaker · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗